Cost-effectiveness of brentuximab vedotin in Hodgkin lymphoma: a systematic review.
Saved in:
| Title: | Cost-effectiveness of brentuximab vedotin in Hodgkin lymphoma: a systematic review. |
|---|---|
| Authors: | Arabloo, Jalal1 arabloo.j@iums.ac.ir, Azari, Samad2, Gorji, Hasan Abolghasem1, Rezapour, Aziz1, Alipour, Vahid1, Ehsanzadeh, Seyed Jafar3 |
| Source: | European Journal of Clinical Pharmacology. Nov2023, Vol. 79 Issue 11, p1443-1452. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
